NIH-funded research R21 grant

Investigating the role of Klebsiella quasipneumoniae in urinary tract infections

Official title: Urovirulence and fimbrial regulation in Klebsiella quasipneumoniae

Funded at University of Texas Dallas · NIH-10910160 · Data updated 2026-11-12

This study is looking at how a specific type of bacteria called Klebsiella quasipneumoniae causes urinary tract infections, especially in women, to help find better ways to treat and prevent these infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Dallas
NIH-funded
Lab location1 site (Richardson, United States)
Project startAugust 18, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$197,640
NIH project number5R21AI169323-02
Project IDNIH-10910160 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adult women who experience recurrent urinary tract infections.

Less likely to help

Patients who do not have urinary tract infections or are not female may not benefit from this research.

What this research studies

This research focuses on understanding how Klebsiella quasipneumoniae, a type of bacteria, contributes to urinary tract infections (UTIs) and recurrent UTIs, particularly in women. The study will explore the virulence factors of this bacterium, which are responsible for its ability to adhere to and invade the urinary tract. By using animal models, researchers aim to evaluate the behavior of these bacteria and their resistance to antibiotics, which is a growing concern in treating UTIs. The findings could lead to better understanding and management of UTIs caused by this understudied pathogen.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options and preventive strategies for women suffering from recurrent urinary tract infections.

How similar studies have gone: While research on Klebsiella pneumoniae is established, the specific focus on Klebsiella quasipneumoniae is relatively novel and has not been extensively studied.

Where this research is happening

  • University of Texas Dallas
    Richardson, United States
    Active

Researchers

  • Principal investigator: De Nisco, Nicole Janell — University of Texas Dallas
  • Study coordinator: De Nisco, Nicole Janell

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.